ANDA 208200

INVAGEN PHARMS

FDA Drug Application

Application #208200

Application Sponsors

ANDA 208200

INVAGEN PHARMS

Marketing Status

• Prescription: 001
• Prescription: 002
• Prescription: 003

Application Products

001	TABLET;ORAL	10MG	0	VILAZODONE HYDROCHLORIDE	VILAZODONE HYDROCHLORIDE
002	TABLET;ORAL	40MG	0	VILAZODONE HYDROCHLORIDE	VILAZODONE HYDROCHLORIDE
003	TABLET;ORAL	20MG	0	VILAZODONE HYDROCHLORIDE	VILAZODONE HYDROCHLORIDE

FDA Submissions

UNKNOWN;	ORIG	1	AP	2021-04-07	STANDARD
UNKNOWN;	ORIG	2	TA	2021-04-07	STANDARD

Submissions Property Types

ORIG	1	Null	7
ORIG	2	Null	31

TE Codes

001	Prescription	AB
002	Prescription	AB
003	Prescription	AB

CDER Filings

INVAGEN PHARMS

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208200
            [companyName] => INVAGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"VILAZODONE HYDROCHLORIDE","activeIngredients":"VILAZODONE HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"VILAZODONE HYDROCHLORIDE","activeIngredients":"VILAZODONE HYDROCHLORIDE","strength":"40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/07\/2021","submission":"ORIG-2","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"04\/07\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-04-07
        )

)